Dashboard
Manage Tickers

TELATELA Bio, Inc.

Nasdaq telabio.com


$ 4.84 $ 0.01 (0.21 %)    

Wednesday, 08-May-2024 15:35:33 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 440.16 $ 1.93 (0.44 %)
DIA $ 390.54 $ 2.25 (0.58 %)
SPY $ 517.36 $ 2.10 (0.41 %)
TLT $ 90.20 $ -0.11 (-0.12 %)
GLD $ 213.71 $ 0.09 (0.04 %)
$ 4.92
$ 4.83
$ 0.00 x 0
$ 4.88 x 100
$ 4.80 - $ 4.91
$ 4.23 - $ 11.26
713,070
na
112.51M
$ 1.08
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-22-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-23-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 05-11-2022 03-31-2022 10-Q
9 03-23-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-14-2021 03-31-2021 10-Q
13 03-25-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
15 08-13-2020 06-30-2020 10-Q
16 05-15-2020 03-31-2020 10-Q
17 03-30-2020 12-31-2019 10-K
18 12-18-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

tela-bio-announces-us-commercial-launch-of-robotic-compatible-ovitex-ihr-designed-for-use-in-laparoscopic-and-robotic-assisted-inguinal-hernia-repair
TELA Bio Announces U.S. Commercial Launch ...
04/15/2024 11:28:42

jmp-securities-reiterates-market-outperform-on-tela-bio-maintains-15-price-target
JMP Securities Reiterates Market Outperfor...
03/22/2024 17:12:06

JMP Securities analyst David Turkaly reiterates TELA Bio (NASDAQ:TELA) with a Market Outperform and maintains $15 price target.

piper-sandler-maintains-overweight-on-tela-bio-lowers-price-target-to-12
Piper Sandler Maintains Overweight on TELA...
03/22/2024 14:15:18

Piper Sandler analyst Matt O'Brien maintains TELA Bio (NASDAQ:TELA) with a Overweight and lowers the price target from $...

tela-bio-expects-full-year-2024-revenue-of-74m-76m-representing-27-30-yy-growth-est-75196m
TELA Bio Expects Full Year 2024 Revenue Of...
03/21/2024 21:00:29

recap-tela-bio-q4-earnings
Recap: TELA Bio Q4 Earnings
03/21/2024 20:20:12

tela-bio-q4-2023-gaap-eps-053-misses-044-estimate-sales-16998m-beat-16392m-estimate
TELA Bio Q4 2023 GAAP EPS $(0.53) Misses $...
03/21/2024 20:16:52

TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.44) by...

tela-bio-disclosed-us-commercial-launch-of-liquifix--the-only-fda-approved-liquid-adhesive-for-internal-use-in-hernia-surgery
TELA Bio Disclosed U.S. Commercial Launch ...
03/21/2024 11:12:32

earnings-scheduled-for-march-21-2024
Earnings Scheduled For March 21, 2024
03/21/2024 10:15:14

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per s...

preview-tela-bios-earnings
Preview: TELA Bio's Earnings
03/20/2024 16:01:01

Core News & Articles
Tela Bio Announced Sale Of Distribution Ri...
03/20/2024 11:13:48

lake-street-reiterates-buy-on-tela-bio-maintains-14-price-target
Lake Street Reiterates Buy on TELA Bio, Ma...
12/27/2023 14:31:21

Lake Street analyst Frank Takkinen reiterates TELA Bio (NASDAQ:TELA) with a Buy and maintains $14 price target.

jmp-securities-maintains-market-outperform-on-tela-bio-lowers-price-target-to-15
JMP Securities Maintains Market Outperform...
11/10/2023 19:52:45

JMP Securities analyst David Turkaly maintains TELA Bio (NASDAQ:TELA) with a Market Outperform and lowers the price target f...

tela-bio-sees-fy23-57m-60m-vs-6164m-est
TELA Bio Sees FY23 $57M-$60M Vs $61.64M Est.
11/09/2023 23:05:23

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
11/09/2023 21:31:10

recap-tela-bio-q3-earnings
Recap: TELA Bio Q3 Earnings
11/09/2023 21:30:47

tela-bio-q3-2023-eps-045-beats-049-estimate-sales-1505m-miss-1620m-estimate
TELA Bio Q3 2023 EPS $(0.45) Beats $(0.49)...
11/09/2023 21:25:54

TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.49) by 8...

earnings-scheduled-for-november-9-2023
Earnings Scheduled For November 9, 2023
11/09/2023 11:52:51

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on re...

tela-bio-13g-filing-shows-first-light-asset-management-llc-holds-1033-stake-in-co
TELA Bio 13G Filing Shows First Light Asse...
10/06/2023 15:52:45

- SEC Filing 

tela-bio-announces-us-commercial-launch-of-ovitex-prs-long-term-resorbable-for-plastic-and-reconstructive-surgery
TELA Bio Announces US Commercial Launch of...
08/16/2023 11:05:52

TELA Bio, Inc. (NASDAQ:TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconst...

tela-bio-sees-fy23-revenue-60m-65m-vs-6207m-est
TELA Bio Sees FY23 Revenue $60M-$65M Vs $6...
08/09/2023 21:42:35

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION